ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Family History Doesn’t Increase Risk Of Ovarian Cancer, Study Says

September 30, 2005

Obey Strikes Again, Earmarks NCI Positions

July 2, 1976

Shubik Group Finally Completes Document On Carcinogenicity Criteria

March 12, 1976

In Brief: Groups agree On Mammography Screening: Money Bill Markups Due After July 4 Recess

June 23, 1989

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

December 5, 1975

DeVita Era At NCI One Of New Programs, Remarkable Stability

August 19, 1988